The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 03, 2024
Filed:
Dec. 06, 2021
Applicant:
Meiji Co., Ltd., Tokyo, JP;
Inventors:
Kentaro Nakamura, Odawara, JP;
Kinya Ashida, Odawara, JP;
Akina Sasayama, Odawara, JP;
Yuri Saito, Odawara, JP;
Assignee:
Meiji Co., Ltd., , JP;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/195 (2006.01); A23L 33/12 (2016.01); A23L 33/175 (2016.01); A61K 31/16 (2006.01); A61K 31/185 (2006.01); A61K 31/198 (2006.01); A61K 31/20 (2006.01); A61K 31/225 (2006.01); A61K 31/23 (2006.01); A61P 3/02 (2006.01); A61P 3/04 (2006.01); A61P 3/10 (2006.01); A61P 9/04 (2006.01); A61P 9/10 (2006.01); A61P 25/00 (2006.01); A61P 25/06 (2006.01); A61P 25/08 (2006.01); A61P 25/16 (2006.01); A61P 25/24 (2006.01); A61P 25/28 (2006.01); A61P 35/00 (2006.01); A61P 43/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/198 (2013.01); A23L 33/12 (2016.08); A23L 33/175 (2016.08); A61K 31/185 (2013.01); A61K 31/20 (2013.01); A61K 31/225 (2013.01); A61K 31/23 (2013.01); A61P 3/02 (2018.01); A61P 3/04 (2018.01); A61P 3/10 (2018.01); A61P 9/04 (2018.01); A61P 9/10 (2018.01); A61P 25/00 (2018.01); A61P 25/06 (2018.01); A61P 25/08 (2018.01); A61P 25/16 (2018.01); A61P 25/24 (2018.01); A61P 25/28 (2018.01); A61P 35/00 (2018.01); A61P 43/00 (2018.01); A23V 2002/00 (2013.01);
Abstract
An object of the present invention is to provide a novel composition for promoting ketone body production. The present invention provides a composition for use in promoting ketone body production, comprising one or more amino acid(s) selected from the group consisting of citrulline, leucine, cysteine, taurine, glutamine, and aspartic acid. The composition according to the present invention may further comprise either or both of a medium-chain fatty acid and a medium-chain fatty acid ester.